Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update (Q37813108)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2010
edit
Language Label Description Also known as
English
Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update
scientific article published on August 2010

    Statements

    Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit